SFE Investment Counsel Decreases Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

SFE Investment Counsel lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 57.0% in the fourth quarter, HoldingsChannel.com reports. The firm owned 582 shares of the medical equipment provider’s stock after selling 772 shares during the quarter. SFE Investment Counsel’s holdings in Intuitive Surgical were worth $304,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. ORG Wealth Partners LLC purchased a new position in Intuitive Surgical in the 3rd quarter valued at approximately $65,000. CX Institutional grew its holdings in Intuitive Surgical by 1.5% in the third quarter. CX Institutional now owns 1,873 shares of the medical equipment provider’s stock valued at $920,000 after purchasing an additional 28 shares during the last quarter. Creative Planning increased its position in shares of Intuitive Surgical by 9.3% in the third quarter. Creative Planning now owns 68,881 shares of the medical equipment provider’s stock valued at $33,839,000 after buying an additional 5,842 shares in the last quarter. Swedbank AB raised its stake in shares of Intuitive Surgical by 1.7% during the 3rd quarter. Swedbank AB now owns 180,043 shares of the medical equipment provider’s stock worth $88,450,000 after buying an additional 2,944 shares during the last quarter. Finally, Petredis Investment Advisors LLC boosted its position in shares of Intuitive Surgical by 0.3% in the 3rd quarter. Petredis Investment Advisors LLC now owns 11,694 shares of the medical equipment provider’s stock worth $5,745,000 after buying an additional 40 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 0.3 %

Shares of NASDAQ ISRG opened at $589.61 on Thursday. The stock has a market capitalization of $210.01 billion, a PE ratio of 91.98, a P/E/G ratio of 5.67 and a beta of 1.39. The firm has a fifty day moving average of $557.70 and a 200-day moving average of $517.49. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Myriam Curet sold 408 shares of the business’s stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the sale, the executive vice president now owns 353 shares of the company’s stock, valued at approximately $208,181.75. This represents a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 6,348 shares of company stock valued at $3,587,582. Company insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the subject of several recent research reports. Wells Fargo & Company raised their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. UBS Group upped their target price on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Truist Financial increased their target price on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday, January 24th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Finally, Stifel Nicolaus increased their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.